Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Public ClinicalTrials.gov record NCT01955161. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To establish efficacy of idalopirdine as adjunctive therapy to donepezil for symptomatic treatment of patients with mild-to-moderate Alzheimer's disease (AD).
Study identification
- NCT ID
- NCT01955161
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 933 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2013
- Primary completion
- Jun 30, 2016
- Completion
- Jun 30, 2016
- Last update posted
- Sep 18, 2017
2013 – 2016
United States locations
- U.S. sites
- 46
- U.S. states
- 23
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| US027 | Birmingham | Alabama | — | — |
| US012 | Phoenix | Arizona | — | — |
| US024 | Little Rock | Arkansas | — | — |
| US053 | Glendale | California | — | — |
| US023 | Imperial | California | — | — |
| US015 | La Jolla | California | — | — |
| US045 | Long Beach | California | — | — |
| US002 | Los Angeles | California | — | — |
| US058 | San Francisco | California | — | — |
| US018 | Santa Ana | California | — | — |
| US060 | Denver | Colorado | — | — |
| US042 | Boca Raton | Florida | — | — |
| US021 | Bradenton | Florida | — | — |
| US050 | Brooksville | Florida | — | — |
| US019 | Orlando | Florida | — | — |
| US038 | Port Charlotte | Florida | — | — |
| US001 | West Palm Beach | Florida | — | — |
| US020 | Atlanta | Georgia | — | — |
| US048 | Kailua | Hawaii | — | — |
| US030 | Chicago | Illinois | — | — |
| US051 | Joliet | Illinois | — | — |
| US040 | Indianapolis | Indiana | — | — |
| US036 | Freeport | Maine | — | — |
| US032 | Newton | Massachusetts | — | — |
| US035 | Kalamazoo | Michigan | — | — |
| US041 | Flowood | Mississippi | — | — |
| US054 | St Louis | Missouri | — | — |
| US046 | Princeton | New Jersey | — | — |
| US028 | Toms River | New Jersey | — | — |
| US044 | Toms River | New Jersey | — | — |
| US049 | Albany | New York | — | — |
| US010 | Amherst | New York | — | — |
| US014 | Manhasset | New York | — | — |
| US008 | New York | New York | — | — |
| US029 | New York | New York | — | — |
| US056 | New York | New York | — | — |
| US037 | Orangeburg | New York | — | — |
| US043 | Staten Island | New York | — | — |
| US007 | Centerville | Ohio | — | — |
| US006 | Columbus | Ohio | — | — |
| US052 | Edmond | Oklahoma | — | — |
| US026 | Portland | Oregon | — | — |
| US057 | Jenkintown | Pennsylvania | — | — |
| US047 | Arlington | Virginia | — | — |
| US025 | Madison | Wisconsin | — | — |
| US004 | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 91 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01955161, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 18, 2017 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01955161 live on ClinicalTrials.gov.